Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-022094
Filing Date
2023-02-14
Accepted
2023-02-14 20:09:49
Documents
1
Period of Report
2023-02-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm236870-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm236870-1_4seq1.xml 4 6859
  Complete submission text file 0001104659-23-022094.txt   8378
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET SUITE 660 VANCOUVER WA 98660
Business Address
Arman Arvin Cyrus (Reporting) CIK: 0001939191 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 23633131